Earnings History Data for Fennec Pharmaceuticals Inc. (FENC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The Company's products include Eniluracil and Sodium Thiosulfate (STS). Fennec Pharmaceuticals Inc., formerly known as Adherex Technologies Inc., is based in United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | FENC | Fennec Pharmaceuticals Inc. | 131.18 | -0.21 | -0.13 | -0.07 | Fennec Pharmaceuticals GAAP EPS of -$0.21 misses by $0.12, revenue of $6.97M misses by $2.01M [11/7/2024 6:18 AM] |
4.36 | -0.59 (-11.92%) |
4.95 | 0.0 (0.00%) |
4.09 - 11.92 | 256,479 | 100,000 | 7,437 | ||
| 13-08-2024 | PM | FENC | Adherex Technologies | 166.00 | -0.20 | 0.06 | 0.00 | Fennec Pharmaceuticals GAAP EPS of -$0.20 misses by $0.17, revenue of $7.26M misses by $3.79M [8/13/2024 6:13 AM] |
5.89 | -0.36 (-5.76%) |
6.26 | 0.01 (0.18%) |
5.30 - 11.92 | 183,348 | 80,000 | 3,135 | ||
| 14-05-2024 | PM | FENC | Fennec Pharmaceuticals Inc. | 259.67 | 0.41 | 0.49 | -0.23 | Fennec Pharmaceuticals GAAP EPS of $0.41, revenue of $25.38M [5/14/2024 6:10 AM] |
7.33 | -2.69 (-26.85%) |
9.27 | -0.75 (-7.49%) |
6.30 - 11.92 | 1,076,035 | 80,000 | 7,887 | ||
| 21-03-2024 | PM | FENC | Fennec Pharmaceuticals Inc. | 294.83 | -0.10 | 0.02 | -0.26 | Fennec Pharmaceuticals GAAP EPS of -$0.10 misses by $0.08 [3/21/2024 11:29 AM] |
11.05 | -0.02 (-0.14%) |
11.50 | 0.43 (3.88%) |
6.30 - 11.92 | 268,814 | 180,000 | 1,358 | ||
| 06-11-2023 | PM | FENC | Fennec Pharmaceuticals Inc. | 184.90 | -0.07 | -0.11 | -0.31 | Fennec Pharmaceuticals GAAP EPS of -$0.07 beats by $0.05, revenue of $6.52M beats by $1.18M [11/6/2023 6:04 AM] |
7.96 | 1.06 (15.36%) |
8.01 | 1.11 (16.09%) |
6.30 - 10.85 | 177,118 | 80,000 | 3,689 | ||
| 03-08-2023 | PM | FENC | Fennec Pharmaceuticals Inc. | 230.66 | -0.21 | -0.18 | -0.19 | Fennec Pharmaceuticals GAAP EPS of -$0.21, revenue of $3.3M [8/3/2023 1:00 PM] |
8.01 | -0.63 (-7.29%) |
8.01 | 0.0 (0.00%) |
6.23 - 10.85 | 252,012 | 60,000 | 504 | ||
| 11-05-2023 | PM | 7:10 AM ET (May 11) |
FENC | Fennec Pharmaceuticals Inc. | 206.54 | -0.23 | -0.21 | -0.14 | Fennec Pharmaceuticals GAAP EPS of -$0.23 misses by $0.02, revenue of $1.68M misses by $0.17M [5/11/2023 6:50 AM] |
7.90 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
5.00 - 10.85 | 93,717 | 80,000 | 0 | |
| 30-03-2023 | PM | FENC | Adherex Technologies | 222.00 | -0.26 | -0.24 | 0.00 | Fennec Pharmaceuticals GAAP EPS of -$0.26 beats by $0.01, revenue of $1.53M beats by $0.79M [3/30/2023 6:49 AM] |
8.50 | 0.18 (2.16%) |
0.0 | 0.0 (0.00%) |
5.00 - 10.85 | 214,569 | 100,000 | 0 | ||
| 11-11-2022 | PM | FENC | Adherex Technologies | 217.00 | -0.31 | -0.17 | 0.00 | Fennec Pharmaceuticals GAAP EPS of -$0.31 misses by $0.13 [11/11/2022 7:16 AM] |
8.18 | 0.0 (0.00%) |
7.87 | -0.31 (-3.79%) |
3.82 - 10.08 | 71,436 | 90,000 | 100 | ||
| 12-08-2022 | PM | 6:00 AM ET (Aug 12) |
FENC | Adherex Technologies | 185.00 | -0.19 | -0.10 | 0.00 | Fennec Pharmaceuticals GAAP EPS of -$0.19 [8/12/2022 8:15 AM] |
6.99 | -0.05 (-0.78%) |
0.0 | 0.0 (0.00%) |
3.82 - 10.08 | 47,349 | 50,000 | 0 | |
| 28-02-2022 | PM | FENC | Adherex Technologies | 132.00 | -0.18 | 3.52 | 0.00 | Fennec Pharmaceuticals GAAP EPS of -$0.18 [2/28/2022 6:41 AM] |
5.58 | 0.15 (2.76%) |
5.15 | -0.28 (-5.16%) |
3.82 - 10.08 | 20,385 | 40,000 | 405 | ||
| 10-11-2021 | PM | FENC | Adherex Technologies | 242.00 | -0.16 | -0.18 | 0.00 | Fennec Pharmaceuticals EPS beats by $0.01 [11/10/2021 6:29 AM] |
9.20 | -0.17 (-1.81%) |
9.36 | -0.01 (-0.11%) |
5.80 - 9.83 | 87,325 | 70,000 | 500 | ||
| 10-08-2021 | PM | 6:00 AM ET (Aug 10) |
FENC | Adherex Technologies Inc. | 177.00 | -0.15 | -0.19 | 0.00 | Fennec Pharmaceuticals EPS beats by $0.04 [8/10/2021 6:13 AM] |
6.99 | 0.02 (0.29%) |
0.0 | 0.0 (0.00%) |
4.80 - 10.67 | 22,971 | 30,000 | 0 | |
| 13-05-2021 | PM | FENC | Fennec Pharmaceuticals Inc. | 153.91 | -0.18 | -0.12 | -0.19 | Fennec Pharmaceuticals EPS beats by $0.03 [5/13/2021 6:28 AM] |
6.20 | 0.22 (3.68%) |
5.98 | 0.0 (0.00%) |
4.80 - 10.67 | 188,860 | 140,000 | 691 | ||
| 16-11-2020 | PM | FENC | Fennec Pharmaceuticals Inc. | 216.79 | -0.24 | -0.18 | -0.09 | Fennec Pharmaceuticals EPS misses by $0.05 [11/16/2020 7:15 AM] |
7.92 | -0.18 (-2.16%) |
8.20 | 0.0 (0.00%) |
4.65 - 10.67 | 68,132 | 145,556 | 1,751 | ||
|
|
||||||||||||||||||
| 14-05-2020 | PM | FENC | Fennec Pharmaceuticals Inc. | 187.63 | -0.19 | -0.19 | -0.13 | Fennec Pharmaceuticals EPS in-line [5/14/2020 6:05 AM] |
7.34 | 0.41 (5.92%) |
7.25 | 0.18 (2.55%) |
3.26 - 8.40 | 144,940 | 185,073 | 1,504 | ||
|
|
||||||||||||||||||